miR ‐34a is upregulated in AIP ‐ mutated somatotropinomas and promotes octreotide resistance-Reference-Cited by-同舟云学术

miR ‐34a is upregulated in AIP ‐ mutated somatotropinomas and promotes octreotide resistance

Published:2020-09-10 Issue:12 Volume:147 Page:3523-3538
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bogner Eva‐Maria¹,Daly Adrian F.²,Gulde Sebastian¹,Karhu Auli³,Irmler Martin⁴,Beckers Johannes⁴⁵⁶,Mohr Hermine¹,Beckers Albert²,Pellegata Natalia S.¹^ORCID

Affiliation:

1. Institute for Diabetes and Cancer Helmholtz Zentrum München Neuherberg Germany

2. Department of Endocrinology Centre Hospitalier Universitaire de Liège, Liège Université Liège Belgium

3. Department of Medical and Clinical Genetics & Genome‐Scale Biology Research Programs Unit University of Helsinki Helsinki Finland

4. Institute of Experimental Genetics, Helmholtz Zentrum München Neuherberg Germany

5. Technische Universität München Chair of Experimental Genetics Freising Germany

6. German Center for Diabetes Research (DZD) Neuherberg Germany

Funder

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33268

Reference61 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015

2. High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium

3. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

4. Genetics of Pituitary Tumor Syndromes

5. Clinical Characterization of Familial Isolated Pituitary Adenomas

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches based on natural products and miRNAs in pituitary adenomas: unveiling therapeutic intervention;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-05

2. The aryl hydrocarbon receptor-interacting protein in cancer and immunity: Beyond a chaperone protein for the dioxin receptor;Journal of Biological Chemistry;2024-04

3. Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism;Frontiers in Endocrinology;2024-02-28

4. Biomarkers of response to treatment in acromegaly;Expert Review of Endocrinology & Metabolism;2023-12-11

5. Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine;Endocrinology and Metabolism;2023-10-31